Researcher
Sumin Bian
- Disciplines:Laboratory medicine, Regenerative medicine, Other basic sciences, Other health sciences, Other medical and health sciences, Medical biotechnology, Pharmaceutics, Drug discovery and development
Affiliations
- Therapeutic and Diagnostic Antibodies (Division)
Member
From1 Oct 2014 → 31 Oct 2018
Publications
1 - 10 of 10
- Evidence to Support Monitoring of Vedolizumab Trough Concentrations in Patients With Inflammatory Bowel Diseases(2018)
Authors: Erwin Dreesen, Bram Verstockt, Sumin Bian, Magali de Bruyn, Gert Van Assche, Marc Ferrante, Ann Gils, Séverine Vermeire
Pages: 1937 - + - Influence of early adalimumab serum levels on immunogenicity and long-term outcome of anti-TNF naive Crohn's disease patients: the usefulness of rapid testing(2018)
Authors: Bram Verstockt, Sumin Bian, Gert Van Assche, Séverine Vermeire, Ann Gils, Marc Ferrante
Pages: 731 - 739 - Development and validation of an optical biosensor for rapid monitoring of adalimumab in serum of patients with Crohn's disease(2018)
Authors: Sumin Bian, Jiadi Lu, Filip Delport, Séverine Vermeire, Dragana Spasic, Jeroen Lammertyn, Ann Gils
Pages: 592 - 596 - Immunoassays for Measuring Serum Concentrations of Monoclonal Antibodies and Anti-biopharmaceutical Antibodies in Patients(2017)
Authors: Sumin Bian
Pages: 316 - 321 - ANTIBODIES TOWARDS VEDOLIZUMAB APPEAR FROM WEEK 2 ONWARDS AND DISAPPEAR UPON TREATMENT(2017)
Authors: Sumin Bian, Ho Tsun Tang, Miet Peeters, Griet Compernolle, Erwin Dreesen, Gert Van Assche, Marc Ferrante, Séverine Vermeire, Ann Gils
Pages: S382 - S382 - Validation of a Drug-Resistant Anti-Adalimumab Antibody Assay to Monitor Immunogenicity in the Presence of High Concentrations of Adalimumab(2017)
Authors: Sumin Bian, Marc Ferrante, Ann Gils
Pages: 468 - 474 - Dose de-escalation to adalimumab 40 mg every 3 weeks in patients with Crohn's disease - a nested case-control study(2017)
Authors: Sumin Bian, Séverine Vermeire, Gert Van Assche, Ann Gils, Marc Ferrante
Pages: 923 - 932 - Antibodies towards vedolizumab appear from week 2 onwards and disappear upon treatment(2017)
Authors: Sumin Bian, HT Tang, M Peeters, G Compernolle, Erwin Dreesen, Gert Van Assche, Marc Ferrante, Séverine Vermeire, Ann Gils
Pages: S44 - S44 - Antibodies Toward Vedolizumab Appear from the First Infusion Onward and Disappear Over Time(2017)
Authors: Sumin Bian, Erwin Dreesen, Gert Van Assche, Marc Ferrante, Séverine Vermeire, Ann Gils
Pages: 2202 - 2208 - Generation and characterization of a unique panel of anti-adalimumab specific antibodies and their application in therapeutic drug monitoring assays(2016)
Authors: Sumin Bian, Thomas Van Stappen, Jeroen Lammertyn, Séverine Vermeire, Ann Gils
Pages: 62 - 67